Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific industry is poised to hold largest revenue share by 2036, propelled by increasing incidence of chronic disorders in the region. Additionally, the increasing healthcare expenditure and growing development of advanced injectable devices for drug delivery in the region are expected to drive the market growth.
North America Market Analysis
Furthermore, in 2036, the market in the North America region is expected to hold the most significant share in the global injectable drug delivery market, on the back of a higher rate of implementation of innovative injectable drug delivery devices for the treatment of various diseases, such as, diabetes mellitus, autoimmune disorders, cancers, and others. Additionally, the rising prevalence of cancer cases and diabetes in the United States is expected to promote the growth of the North America injectable drug delivery market.
January 2021: Novo Nordisk A/S, announced the approval from the US Food and Drug Administration for semaglutide, which is an injectable treatment for chronic weight management in adults such as high blood pressure, high cholesterol, and others.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?